Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ:REGN)

618.20 +5.70 (+0.93%)
Streaming Delayed Price Updated: 1:29 PM EDT, Jun 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Regeneron Pharmaceuticals

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
63 64 Next >
News headline image
Why REGENERON PHARMACEUTICALS (NASDAQ:REGN) qualifies as a quality stock. ↗
This article explores why quality investors may have a look at REGENERON PHARMACEUTICALS (NASDAQ:REGN) 
Via Chartmill
News headline image
Could Regeneron Stock Help You Retire a Millionaire? ↗
The blossoming biotech might give more than a nudge to investors in this project. 
Via The Motley Fool
News headline image
3 health care stocks off to strong starts in 2024
With the bullish news flow lately, the market has taken a liking to health care stocks in recent weeks - including these three early 2024 gainers. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Beyond The Numbers: 13 Analysts Discuss Regeneron Pharmaceuticals Stock ↗
 
Via Benzinga
News headline image
Regeneron Slumps As Its Biggest Moneymaker Falls Short; Exelixis Dives On Guidance Woes ↗
Shares of both skidded early Monday as the annual J.P. Morgan Healthcare Conferenced kicked off In San Francisco. 
Via Investor's Business Daily
News headline image
3 Top Biotech Stocks Worth Adding To Your Portfolio In 2024 ↗
Given the continuous need for innovative medical treatments, the biotech industry may be a haven despite its inherent volatility and an uncertain macroeconomic environment. Here are three top biotech... 
Via Talk Markets
News headline image
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Regeneron Pharmaceuticals? ↗
 
Via Benzinga
News headline image
Regeneron to Report Fourth Quarter and Full Year 2023 Financial and Operating Results and Host Conference Call and Webcast on February 2, 2024
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Kymera Therapeutics Stock Whiplash: Shares Soar, Then Tumble After $275 Million Offering ↗
Shares soared and then tumbled Friday after the company offered $275 million in public shares. 
Via Investor's Business Daily
News headline image
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain. 
Via Investor's Business Daily
News headline image
Unpacking the Latest Options Trading Trends in Regeneron Pharmaceuticals ↗
 
Via Benzinga
News headline image
Where Will Regeneron Pharmaceuticals Be in 1 Year? ↗
Can the stock continue its market-beating ways? 
Via The Motley Fool
News headline image
14 Analysts Assess Regeneron Pharmaceuticals: What You Need To Know ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
2 Healthcare Stocks That Turned $1,000 Into $2,400 (or More) ↗
These innovative biotechs likely aren't done rewarding their shareholders. 
Via The Motley Fool
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Records 52-Week High Wednesday Morning
Via Investor Brand Network
News headline image
2 gene-editing stocks reshaping hereditary disease treatments
Gene-editing companies are making headlines for the potential to reshape the future of healthcare and the treatment of hereditary diseases. The U.S. Federal 
Via MarketBeat
News headline image
Regeneron Celebrates Legal Win: Court Upholds Eylea Medication Patent ↗
Wednesday, a court ruling that found Viatris Inc's (NASDAQ: 
Via Benzinga
News headline image
Price Over Earnings Overview: Regeneron Pharmaceuticals ↗
 
Via Benzinga
News headline image
Thoughts For Thursday: With War Clouds As A Backdrop The Market Is Set To End The Year On A High ↗
The market looks set to end 2023 on a high note, but 2024 is less certain, particularly because though, the US does not want further action in the Gulf, it seems, Iran via its proxies is gaming for... 
Via Talk Markets
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Visualized: The Top S&P 500 Stocks Over 20 Years ↗
Via Talk Markets
Topics Stocks
News headline image
7 Undervalued Nasdaq-100 Stocks for Bargain Hunters ↗
Though tech innovators blossomed this year, you can still find undervalued deals. 
Via InvestorPlace
News headline image
$1000 Invested In Regeneron Pharmaceuticals 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Regeneron Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
It's Almost 2024: 3 Top Stocks to Buy Before the New Year ↗
You can pick these players up for a great price right now. 
Via The Motley Fool
News headline image
AI Meets Biotech: 3 Top Stocks Transforming Medical Science ↗
The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
3 Stocks to Buy Before 2024 That Can Set You Up For Life ↗
These stocks are still relatively cheap, but don't expect them to stay that way for long. 
Via The Motley Fool
News headline image
Reasonable growth and debt and a high ROIC for REGENERON PHARMACEUTICALS (NASDAQ:REGN). ↗
Exploring REGENERON PHARMACEUTICALS (NASDAQ:REGN)'s quality characteristics. 
Via Chartmill
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
63 64 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.